ISOPRENALINE HYDROCHLORIDE MEDICIANZ isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

isoprenaline hydrochloride, Quantity: 200 microgram

Commercializzato da:

Medsurge Pharma Pty Ltd

Forma farmaceutica:

Injection, solution

Composizione:

Excipient Ingredients: hydrochloric acid; sodium citrate dihydrate; citric acid; sodium chloride; water for injections; sodium hydroxide; disodium edetate

Via di somministrazione:

Intracardial, Intramuscular, Intravenous Bolus, Intravenous Infusion, Subcutaneous

Confezione:

25 x 1mL ampoules, 5 x 1mL ampoules

Tipo di ricetta:

(S4) Prescription Only Medicine

Indicazioni terapeutiche:

Isoprenaline Hydrochloride is indicated: For mild or transient episodes of heart block that do not require electric shock or pacemaker therapy.,For serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation). (See Section 4.3 Contraindications),For use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available. (See Section 4.3 Contraindications.),For bronchospasm occurring during anaesthesia.,As an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cardiogenic shock. (See Section 4.4 Special warnings and precautions for use).

Dettagli prodotto:

Visual Identification: Clear, colorless to slightly yellow colour solution. Practically free from any visible particles.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stato dell'autorizzazione:

Registered

Data dell'autorizzazione:

2022-02-10